Loading insider details...
Latest Form 4 (Apr 3, 2026): Disposition to Issuer of 667 LYRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 3, 2026 | Lyra Therapeutics, Inc. (LYRA) | Disposition to Issuer | 667 | n/a |
| Jan 8, 2026 | Lyra Therapeutics, Inc. (LYRA) | Sale | 769 | $2.6K |
| Jul 15, 2025 | Lyra Therapeutics, Inc. (LYRA) | Sale | 684 | $6.1K |
| Jan 10, 2025 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 420,000 | n/a |
| Oct 18, 2024 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 100,000 | n/a |
| Feb 1, 2024 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 200,000 | n/a |
| Feb 2, 2023 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 140,000 | n/a |
| Feb 16, 2022 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 15,605 | n/a |
| Sep 15, 2021 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 104,000 | n/a |